Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications studying cancer adverse outcome nononcological therapies review food drug
… National Comprehensive Cancer Network (NCCN) 2022 Annual Conference Share on: … will be presented at the National Comprehensive Cancer Network (NCCN) 2022 Annual Conference. Spira A, Liao …
… BRCA Mutation Share on: May 4, 2021 Mutations in breast cancer susceptibility genes are known to increase the risk of inheriting breast cancer. Genetic testing enables persons to determine if they … Cancer: Results From a US Retrospective Medical Records Review Study . Elias Obeid, Rohan C. Parikh , Elizabeth …
Health Economics and Outcomes Research (HEOR) Strategy Plans and Gap Analyses for a Treatment Targeting Multiple Rare Diseases OPPORTUNITY Our client had a product in multiple phase 2 and 3 clinical trials for the treatment of numerous rare disease …
… in Patients with Inadequate Response to Disease-Modifying Therapies in Relapsing-Remitting Multiple Sclerosis in Italy. … in Patients With Inadequate Response to Disease-Modifying Therapies in Relapsing-Remitting Multiple Sclerosis in Spain. … burden. While there is no cure for MS, disease-modifying therapies have been shown to have an impact on MS-related …
… health illnesses. Our experience includes: Alcohol and drug abuse and dependence Anxiety disorders, including Acute … models (cost effectiveness, budget impact, Markov) Drug utilization studies Economic burden of illness studies …
… for over a decade in fields like HIV, cardiovascular, and cancer research. In this study we explored an alternative to … used the emulation of a target trial of breast cancer screening using Medicare claims data: we estimated, in … women over 70 years old who were just screened for breast cancer, what was the effect of stopping screening vs. …
… impacts measured in this study were developed based on the Outcome Measures in Rheumatology (OMERACT) core outcome set … (preferred by 38% of respondents), and 74% prioritized therapies that significantly improved joint-related symptoms … to treatment outcomes." The results of this study can help drug developers know where to focus their research. …
Diabetes & Endocrine Disorders A Wealth of Experience We have collaborated with our clients on projects to research diabetes and endocrine disorders, diabetes and endocrine treatments, and complications and comorbidities of diabetes and endocrine …
… reviews and distributional cost-effectiveness analysis Review social determinants data and tools to leverage in … of pharmaceuticals, medical devices, diagnostics, digital therapies, or public health interventions Health equity …
… data sources Decision-analytic models Disease prevalence Drug utilization studies Economic analyses of clinical trial … burden of illness studies Epidemiology reports for orphan drug applications and pediatric investigational plans …